Skip to main content
Equibles

SIG BROKERAGE, LP

Broker-Dealer

Position in CMPX — Compass Therapeutics, Inc.

CIK 1094429 BALA CYNWYD, PA
Back to CMPX Full portfolio

Position in CMPX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$31,746
-$44,937 QoQ
Shares Held
14,496
0.0% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#161
of 216 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CMPX Over Time

Shares Held

Position Value (USD)

Derivatives in CMPX

reported options exposure · as of Mar 31, 2025
CallValue
$76,000
CallShares
40,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SIG BROKERAGE, LP holds $14,503,065 across 7 Biotechnology names. CMPX ranks #7 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 22,390 $11,121,784
2 DNTH
Dianthus Therapeutics, Inc. /DE/
 24,600 $2,398,008
3 RVMD
Revolution Medicines, Inc.
 2,846 $532,998
4 DFTX
Definium Therapeutics, Inc.
 6,563 $308,723
5 GALT
Galectin Therapeutics Inc
 13,596 $63,085
6 NMRA
Neumora Therapeutics, Inc.
 27,483 $46,721
7 CMPX
Compass Therapeutics, Inc.
This page 		14,496 $31,746

All Filings in CMPX

Export CSV
6 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $31,746 14,496
2026-03-31 $76,683 14,496
2025-12-31 $91,698 17,076
2025-09-30 $92,277 26,365
2025-06-30 $94,621 36,393
2025-03-31 $76,000 40,000